Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GNAI3 | P08754 | 1/20 | 0.52 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.52 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.52 |
| ▸ | BBOX1 | O75936 | 2/20 | 0.48 |
| ▸ | LMNA | P02545 | 4/20 | 0.47 |
| ▸ | APOBEC3A | P31941 | 2/20 | 0.47 |
| ▸ | APOBEC3G | Q9HC16 | 2/20 | 0.47 |
| ▸ | TSHR | P16473 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | BLM | P54132 | 1/20 | 0.47 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.39 |
| ▸ | CDC25A | P30304 | 1/20 | 0.37 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.36 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.36 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3765529 | 1.00 | GNAI3 (0.52) | GNAI3GNAO1GNAI1BBOX1LMNA | |
| SCHEMBL899013 | 1.00 | GNAI3 (0.52) | GNAI3GNAO1GNAI1BBOX1LMNA | |
| SCHEMBL5283667 | 1.00 | GNAI3 (0.52) | GNAI3GNAO1GNAI1BBOX1LMNA | |
| SCHEMBL5307532 | 1.00 | GNAI3 (0.52) | GNAI3GNAO1GNAI1BBOX1LMNA | |
| SCHEMBL372263 | 1.00 | GNAI3 (0.52) | GNAI3GNAO1GNAI1BBOX1LMNA | |
| SCHEMBL5284113 | 1.00 | GNAI3 (0.52) | GNAI3GNAO1GNAI1BBOX1LMNA | |
| SCHEMBL3771595 | 1.00 | GNAI3 (0.52) | GNAI3GNAO1GNAI1BBOX1LMNA | |
| SCHEMBL5297910 | 1.00 | GNAI3 (0.52) | GNAI3GNAO1GNAI1BBOX1LMNA | |
| SCHEMBL372381 | 1.00 | GNAI3 (0.52) | GNAI3GNAO1GNAI1BBOX1LMNA | |
| SCHEMBL18686073 | 1.00 | GNAI3 (0.52) | GNAI3GNAO1GNAI1BBOX1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 298 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11788171-B2 | Methods of recovering an elemental rare earth metal, and methods of forming a rare earth metal | BATTELLE ENERGY ALLIANCE, LLC (US) | 2023-10-17 | — | — | US | claimed |
| US-11149356-B2 | Methods of forming metals using ionic liquids | BATTELLE ENERGY ALLIANCE, LLC (US) | 2021-10-19 | — | — | US | claimed |
| US-20210292870-A1 | METHODS OF RECOVERING AN ELEMENTAL RARE EARTH METAL, METHODS OF FORMING A RARE EARTH METAL, AND RELATED SYSTEMS | UNITED STATES DEPARTMENT OF ENERGY | 2021-09-23 | — | — | US | claimed |
| US-20190186031-A1 | METHODS OF FORMING METALS USING IONIC LIQUIDS | UNITED STATES DEPARTMENT OF ENERGY | 2019-06-20 | — | — | US | claimed |
| EP-3151314-B1 | LITHIUM METAL BATTERY | SAMSUNG ELECTRONICS CO LTD (KR) | 2018-08-01 | — | — | EP | claimed |
| US-20170098858-A1 | LITHIUM METAL BATTERY | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2017-04-06 | — | — | US | claimed |
| EP-3151314-A1 | LITHIUM METAL BATTERY | Samsung Electronics Co., Ltd. (KR) | 2017-04-05 | — | — | EP | claimed |
| US-8921589-B2 | Electrolyte formulations | MERCK PATENT GMBH (DE) | 2014-12-30 | — | — | US | claimed |
| US-8829201-B2 | Electrolyte Formulations | MERCK PATENT GMBH (DE) | 2014-09-09 | — | — | US | claimed |
| US-20120318360-A1 | Electrolyte Formulations | MERCK PATENT GMBH (DE) | 2012-12-20 | — | — | US | claimed |
| US-20090242414-A1 | ELECTRONCHEMICAL DEPOSITION OF TANTALUM AND/OR COPPER IN IONIC LIQUIDS | MERCK PATENT GMBH (DE) | 2009-10-01 | — | — | US | claimed |
| EP-1951934-B1 | ELECTROCHEMICAL DEPOSITION OF SELENIUM IN IONIC LIQUIDS | MERCK PATENT GMBH (DE) | 2009-08-19 | — | — | EP | claimed |
| US-20080210566-A1 | Electrochemical Deposition of Selenium in Ionic Liquids | MERCK PATENT GESELLSCHAFT (DE) | 2008-09-04 | — | — | US | claimed |
| EP-1951934-A1 | ELECTROCHEMICAL DEPOSITION OF SELENIUM IN IONIC LIQUIDS | Merck Patent GmbH (DE) | 2008-08-06 | — | — | EP | claimed |
| EP-1831433-A2 | ELECTROCHEMICAL DEPOSITION OF TANTALUM AND/OR COPPER IN IONIC LIQUIDS | Merck Patent GmbH (DE) | 2007-09-12 | — | — | EP | claimed |
| WO-2007039035-A1 | ELECTROCHEMICAL DEPOSITION OF SELENIUM IN IONIC LIQUIDS | MERCK PATENT GMBH (DE) | 2007-04-12 | — | — | WO | claimed |
| WO-2006061081-A2 | ELECTROCHEMICAL DEPOSITION OF TANTALUM AND/OR COPPER IN IONIC LIQUIDS | MERCK PATENT GMBH (DE) | 2006-06-15 | — | — | WO | claimed |
| US-20260121095-A1 | Advanced Ion Exchange Membranes And Applications Thereof | WILLIAMS RICHARD KENT (US) | 2026-04-30 | — | — | US | disclosed |
| CN-1667071-A | Adhesive composition, adhesive sheets and surface protective film | NITTO DENKO CORP (JP) | 2005-09-14 | — | — | CN | disclosed |
| US-20050197450-A1 | Pressure-sensitive adhesive composition, pressure-sensitive adhesive sheets and surface protecting film | NITTO DENKO CORPORATION (JP) | 2005-09-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260121095-A1 | Advanced Ion Exchange Membranes And Applications Thereof | MYOC, MB, MYOF | GNAI3 3402/4885GNAO1 2144/4885GNAI1 3026/4885 |
| US-20120318360-A1 | Electrolyte Formulations | NHERF1, HCN4, DDT | GNAI3 522/4885GNAO1 940/4885GNAI1 624/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.